[1]
Raybarman, C. and Bhattacharjee, S. 2021. Aerosolized type II transmembrane serine protease 2 inhibitor to combat COVID-19: a proposal. International Journal of Contemporary Pediatrics. 8, 12 (Nov. 2021), 1996–1997. DOI:https://doi.org/10.18203/2349-3291.ijcp20214544.